Circulating immune complexes in IgA deficiency.

Area of Science:

• Immunology
• Clinical Medicine

Background:

• Serum IgA deficiency is a common primary immunodeficiency.
• The role of circulating immune complexes (IC) in IgA deficiency is not fully understood.
• Mucosal immune dysregulation is implicated in IgA deficiency pathogenesis.

Purpose of the Study:

• To investigate the presence and characteristics of circulating immune complexes (IC) in patients with serum IgA deficiency.
• To explore the association between IC and clinical manifestations in IgA-deficient individuals.
• To examine the relationship between IC and anti-IgA antibodies in this patient cohort.

Main Methods:

• Solid phase C1q radioimmunoassay was used to detect IgG class IC.
• Cryoglobulins and polyethylene glycol (PEG) precipitation were employed as additional methods for IC detection.
• Serum samples were analyzed for the presence of anti-IgA antibodies.

Main Results:

• Circulating immune complexes (IC) were detected in 16 out of 31 (51.6%) IgA-deficient patients.
• Cryoglobulins and PEG precipitation confirmed IC in a significant proportion of patients.
• Seven patients exhibited clinical symptoms potentially related to IC, including glomerulonephritis, polyarthritis, vasculitis, and thyroiditis.
• Serum anti-IgA antibodies were found in 15 out of 31 (48.4%) patients, but their presence did not directly correlate with IC levels.
• Anti-IgA antibodies were found within the isolated IC in 8 patients.

Conclusions:

• Circulating immune complexes (IC) are frequently present in patients with serum IgA deficiency.
• These IC may contribute to the pathogenesis of various clinical diseases observed in IgA deficiency.
• Defective antigen exclusion at the mucosal level is proposed as a significant contributor to the IC burden in IgA deficiency.